TY - JOUR
T1 - Quality improvement project to decrease delivery room intubations in preterm infants
AU - Kakkilaya, Venkatakrishna
AU - Jubran, Ihab
AU - Mashruwala, Vaishali
AU - Ramon, Emma
AU - Simcik, Valerie N.
AU - Marshall, Marjory
AU - Brown, L. Steven
AU - Jaleel, Mambarambath A.
AU - Kapadia, Vishal S.
N1 - Funding Information:
indicated they have no financial relationships relevant to this article to disclose. FUNDING: Supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Institutes of Health grant 1K23HD083511-01A1 (to Dr Kapadia). Funded by the National Institutes of Health (NIH).
Publisher Copyright:
Copyright © 2019 by the American Academy of Pediatrics.
PY - 2019/2
Y1 - 2019/2
N2 - BACKGROUND AND OBJECTIVES: Avoidance of delivery room intubation (DRI) reduces death or bronchopulmonary dysplasia (BPD) in preterm neonates. Our objective with this quality improvement project was to decrease DRI rates by improving face mask positive pressure ventilation (Fm-PPV) among infants born ≤29 weeks’ gestation. METHODS: Key drivers of change were identified from a retrospective review of resuscitation records. A resuscitation bundle to optimize Fm-PPV including the use of a small round mask and end-tidal CO 2 detectors, increasing peak inspiratory pressure when indicated, and debriefing after each intubation were implemented in consecutive plan-do-study-act cycles. The DRI rate was tracked by using a control chart. Resuscitation practice and outcomes of pre–quality improvement cohort (QIC) (January 2014–September 2015) were compared with post-QIC (October 2015–December 2016). RESULTS: Of the 314 infants who were resuscitated, 180 belonged to the pre-QIC and 134 to the post-QIC. The antenatal steroid administration rate was higher in the post-QIC (54% vs 88%). More infants in the post-QIC had resolution of bradycardia after Fm-PPV (56% vs 77%, P = .02). Infants in the post-QIC had lower DRI rates (58% vs 37%, P < .01), lower need for mechanical ventilation (85% vs 70%, P < .01), lower rates of BPD (26% vs 13%, P < .01), and severe retinopathy of prematurity (14% vs 5%, P = .01). Rates of DRI, BPD, and severe retinopathy of prematurity remained lower even after controlling for the potential confounders. CONCLUSIONS: Implementation of a resuscitation bundle decreased the DRI rate and improved outcomes of preterm infants.
AB - BACKGROUND AND OBJECTIVES: Avoidance of delivery room intubation (DRI) reduces death or bronchopulmonary dysplasia (BPD) in preterm neonates. Our objective with this quality improvement project was to decrease DRI rates by improving face mask positive pressure ventilation (Fm-PPV) among infants born ≤29 weeks’ gestation. METHODS: Key drivers of change were identified from a retrospective review of resuscitation records. A resuscitation bundle to optimize Fm-PPV including the use of a small round mask and end-tidal CO 2 detectors, increasing peak inspiratory pressure when indicated, and debriefing after each intubation were implemented in consecutive plan-do-study-act cycles. The DRI rate was tracked by using a control chart. Resuscitation practice and outcomes of pre–quality improvement cohort (QIC) (January 2014–September 2015) were compared with post-QIC (October 2015–December 2016). RESULTS: Of the 314 infants who were resuscitated, 180 belonged to the pre-QIC and 134 to the post-QIC. The antenatal steroid administration rate was higher in the post-QIC (54% vs 88%). More infants in the post-QIC had resolution of bradycardia after Fm-PPV (56% vs 77%, P = .02). Infants in the post-QIC had lower DRI rates (58% vs 37%, P < .01), lower need for mechanical ventilation (85% vs 70%, P < .01), lower rates of BPD (26% vs 13%, P < .01), and severe retinopathy of prematurity (14% vs 5%, P = .01). Rates of DRI, BPD, and severe retinopathy of prematurity remained lower even after controlling for the potential confounders. CONCLUSIONS: Implementation of a resuscitation bundle decreased the DRI rate and improved outcomes of preterm infants.
UR - http://www.scopus.com/inward/record.url?scp=85061097032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061097032&partnerID=8YFLogxK
U2 - 10.1542/peds.2018-0201
DO - 10.1542/peds.2018-0201
M3 - Article
C2 - 30602545
AN - SCOPUS:85061097032
SN - 0031-4005
VL - 143
JO - Pediatrics
JF - Pediatrics
IS - 2
M1 - e20180201
ER -